Probiotics Plus Dietary Fiber Supplements Attenuate Olanzapine-Induced Weight Gain in Drug-Naïve First-Episode Schizophrenia Patients: Two Randomized Clinical Trials
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Probiotics Plus Dietary Fiber Supplements Attenuate Olanzapine-Induced Weight Gain in Drug-Naïve First-Episode Schizophrenia Patients: Two Randomized Clinical Trials
Authors
Keywords
-
Journal
SCHIZOPHRENIA BULLETIN
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2022-04-17
DOI
10.1093/schbul/sbac044
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pro-cognitive effect of a prebiotic in psychosis: A double blind placebo controlled cross-over study
- (2019) Amy Chia-Ching Kao et al. SCHIZOPHRENIA RESEARCH
- Clinical and metabolic response to vitamin D plus probiotic in schizophrenia patients
- (2019) Amir Ghaderi et al. BMC Psychiatry
- Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
- (2019) Maximilian Huhn et al. LANCET
- Probiotics and prebiotics: focus on psychiatric disorders – a systematic review
- (2019) Renata S D Barbosa et al. NUTRITION REVIEWS
- The effects of probiotics and synbiotic supplementation on glucose and insulin metabolism in adults with prediabetes: a double-blind randomized clinical trial
- (2018) Nazila Kassaian et al. ACTA DIABETOLOGICA
- Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes
- (2018) Liping Zhao et al. SCIENCE
- Effects of probiotic supplements on insulin resistance in gestational diabetes mellitus: A double-blind randomized controlled trial
- (2018) Athasit Kijmanawat et al. Journal of Diabetes Investigation
- Gut Microbiota Modulation and Its Relationship with Obesity Using Prebiotic Fibers and Probiotics: A Review
- (2017) Dinesh K. Dahiya et al. Frontiers in Microbiology
- Metformin treatment of antipsychotic-induced dyslipidemia: an analysis of two randomized, placebo-controlled trials
- (2016) R-R Wu et al. MOLECULAR PSYCHIATRY
- Probiotics and prebiotic fiber for constipation associated with Parkinson disease
- (2016) Michela Barichella et al. NEUROLOGY
- The gut microbiota and host health: a new clinical frontier
- (2015) Julian R Marchesi et al. GUT
- Use of the second-generation antipsychotic, risperidone and secondary weight gain are associated with an altered gut microbiota in children
- (2015) S M Bahr et al. Translational Psychiatry
- Risperidone-induced weight gain is mediated through shifts in the gut microbiome and suppression of energy expenditure
- (2015) Sarah M. Bahr et al. EBioMedicine
- The effects of co-administration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: A randomized double-blind controlled clinical trial
- (2014) Sin Ji Lee et al. CLINICAL NUTRITION
- A Clinician's Primer on the Role of the Microbiome in Human Health and Disease
- (2014) Sahil Khanna et al. MAYO CLINIC PROCEEDINGS
- The Antipsychotic Olanzapine Interacts with the Gut Microbiome to Cause Weight Gain in Mouse
- (2014) Andrew P. Morgan et al. PLoS One
- Effect of Lactobacillus salivarius Ls-33 on fecal microbiota in obese adolescents
- (2013) Nadja Larsen et al. CLINICAL NUTRITION
- Richness of human gut microbiome correlates with metabolic markers
- (2013) Emmanuelle Le Chatelier et al. NATURE
- Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat
- (2013) K J Davey et al. Translational Psychiatry
- Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters
- (2012) Kieran J. Davey et al. PSYCHOPHARMACOLOGY
- Systematic Review of Early Cardiometabolic Outcomes of the First Treated Episode of Psychosis
- (2011) Debra L. Foley et al. ARCHIVES OF GENERAL PSYCHIATRY
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
- (2011) Marc De Hert et al. Nature Reviews Endocrinology
- Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
- (2009) Christoph U. Correll JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search